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Personality disorder is now being accepted as an important condition in mainstream psychiatry across the world. Although it often re­
mains unrecognized in ordinary practice, research studies have shown it is common, creates considerable morbidity, is associated with 
high costs to services and to society, and interferes, usually negatively, with progress in the treatment of other mental disorders. We now 
have evidence that personality disorder, as currently classified, affects around 6% of the world population, and the differences between 
countries show no consistent variation. We are also getting increasing evidence that some treatments, mainly psychological, are of value 
in this group of disorders. What is now needed is a new classification that is of greater value to clinicians, and the WPA Section on Per­
sonality Disorders is currently undertaking this task.
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In the last 50 years, personality disorder has achieved a 
level of understanding and, indeed, respectability that now 
allows it to be considered as an equal partner with other 
mental disorders. Before the 1960s, personality disorder, 
with the possible exception of the antisocial group, was con­
sidered an unreliable and imprecise diagnosis with little or 
no clinical value. Since then, however, and particularly since 
the introduction of DSM-III in 1980, there has been increas­
ing recognition that personality disorder, despite many im­
perfections in its classification, can be described and rated 
reliably. Personality disorder has been shown to have an im­
portant influence on the outcome of other mental disorders 
when present as a comorbid condition, and it may benefit 
from specific treatment. This article discusses these findings 
from a global perspective, as this has particular relevance to 
low-income countries in which personality disorder has un­
til recently been seldom studied.
EPIDEMIOLOGY
Although national morbidity studies of mental illness 
have now become more frequent in developed countries, 
they do not often record personality disorder. One of the 
main reasons for this is the difficulty in conducting assess­
ments of personality disorder, especially with lay interview­
ers. As a consequence, there are only a handful of such stud­
ies of the literature (1-3). However, with the increasing use 
of short screening assessments for personality disorder (4,5), 
it is possible to conduct such assessments with lay interview­
ers and provide valuable data.
Three major studies of the epidemiology of personality 
disorder have now been published in the last five years. The 
results are summarized in Table 1. By far the largest of these 
studies was conducted across 10 different countries, includ­
ing six low- or middle-income countries. This study is par­
Table 1 Study methods and prevalence of personality disorder from recently published epidemiological studies
Author, year (ref.) Country Method Prevalence (%) Screening instrument
Huang et al, 2009 (6) Western Europe (WE),
Colombia (C),
Lebanon (L),
Mexico (M), Nigeria (N), 





Multiple imputation used to predict 
personality disorder scores using a three 
part simulation procedure. Rates of 
personality disorder calculated as means 










33-item screening questions 
from the International 
Personality Disorder 
Examination (IPDE)
Coid et al, 2006 (3) England, Wales, Scotland Survey of a stratified sample of 15,000 
households (n=628)
4.4 Screening questionnaire of
SCID-II
Grant et al, 2004 (7) United States of America Random sample
(National Epidemiologic Survey on 
Alcohol and Related Conditions) 
(n=43,093)
14.8 Alcohol Use Disorder and 
Associated Disabilities 
Interview Schedule, DSM- 
IV Version
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ticularly significant because it demonstrates that personality 
disorders are no less prevalent outside Europe, North Amer­
ica and Australia, where all previous data have been col­
lected. The study is also important because it shows that 
problems in social functioning among people with personal­
ity disorder are clinically significant, even when the impact 
of other comorbid mental health problems has been con­
trolled for (6).
HOW COMORBID PERSONALITY DISORDER 
INFLUENCES OTHER MENTAL DISORDERS
As the identification of personality pathology has become 
increasingly robust, it has become possible to turn our atten­
tion to how this group of disorders affect other mental dis­
orders, such as affective and psychotic disorders, more com­
monly identified and treated within mental health settings. 
Although the community prevalence of personality disorder 
appears to range from 3 to 10%, it is, as would be expected, 
much higher in secondary care settings (8,9). As such, it 
would be expected to impact on psychopathology, outcome 
and service provision. The research undertaken to date, al­
though limited in a similar fashion to the epidemiological 
data, would broadly support this view.
The best studied association is between depressive disor­
ders and personality status. More than 60 studies have 
looked at the correlation between personality disorder and 
depression and, when combined using a meta-analytic ap­
proach, they confirm that people with a personality disorder 
are approximately twice as likely not to recover from a de­
pressive episode as those with no personality disorder (un­
published data). This data is very similar to initial findings 
of poorer outcome in depression when personality pathol­
ogy is present (10). Studies do not make it clear whether this 
poorer outcome is due to the lack of treatments directed at 
the personality pathology or if personality disorder acts as a 
diathesis in these conditions (11).
The findings in psychotic mental illness are far less clear. 
This field of research is less well developed and even the 
prevalence of personality pathology ranges from 4.5 to 
100%. This huge variation appears to be related to the coun­
try of the study, the care provided and the tools used to mea­
sure personality (12). It is not clear that personality mea­
sures in psychosis are reliable (13). Outcomes in this group 
are also poorly studied (14), although there are peripheral 
indicators that personality disorder in this group often shows 
itself in terms of violence (15), crime (16), and hospital re­
admission (17).
Other research has examined the interactions of personal­
ity pathology and major mental illness within community 
and secondary care settings. This also supports the probabil­
ity of poorer outcomes in personality disordered patients 
who are, by and large, treated for affective and psychotic 
disorders. Two-year outcomes in an Australian cohort 
showed the personality facet of neuroticism to be one of the 
few correlates predictive of poor outcome in those with men­
tal illnesses (18). Cross-sectional data has also suggested per­
sonality disorder, particularly its severity, to be associated 
with both higher social needs and greater social dysfunction 
in patients in a secondary care setting in England (19).
Studies such as these suggest that personality dysfunction 
has a negative effect on function and outcome, but remains 
relatively undertreated. Why is this? The answer to this 
question is potentially multifaceted, although clinicians’ at­
titudes toward this difficult to manage group are important. 
For more than two decades, there has been the suggestion 
that mental health clinicians do not like patients with per­
sonality disorders (20), and recent evidence suggests that 
clinicians perceive patients with personality disorders as 
more difficult, despite the objective evidence failing to sup­
port such a view (21). These attitudes may adversely affect 
delivery of health care provision and as such make it more 
difficult for patients with personality disorder and comorbid 
mental disorders to access and receive appropriate manage­
ment for either disorder.
It therefore appears that people with personality disorder 
and comorbid personality disorder have poorer outcomes, 
function less well in society and are stigmatized by clinicians 
in secondary services, reducing the odds they will receive 
optimum care. This is a combination which is potentially 
expensive when considering the delivery of health and so­
cial care services.
COST OF PERSONALITY DISORDER
As part of a recent report on the economic burden of 
mental health problems in England, the King’s Fund esti­
mated the health and social care service costs of all people 
with personality disorder who are in contact with their gen­
eral practitioners at £704 million per year (22). When pro­
ductivity losses were included, the cost rose to £7.9 billion 
per year. Soeteman et al (23) used a similar approach to 
calculate the cost of personality disorder by using data from 
health and social care contacts for people attending special­
ist personality disorder services. They calculated the total 
burden of personality disorder in the Netherlands to be 
£11,126 per patient.
These studies can be considered a useful starting point, 
but they do not provide an estimate of the total economic 
burden of personality disorder, because both of them used 
information on people who were in contact with services. 
Whilst service attenders provide useful opportunistic sam­
ples for research purposes, they are not representative of the 
personality disorder population as a whole. Indeed, we 
know that many of those with personality disorder are un­
known to services (24), reject treatment rather than seek it 
(25), or are in contact with services but have a different pri­
mary diagnosis (26). Thus, to date, the true cost of personal­
ity disorder remains unknown, but it is certainly substantial, 
falling to many service providing sectors (health, social ser­
vices, criminal justice) as well as to the economy more wide­
ly (inability to work and premature death).
EVIDENCE OF TREATMENT EFFECTIVENESS
Most of the research conducted into the treatment of per­
sonality disorder has focused on those with borderline per­
sonality disorder. Systematic reviews of previously published 
randomized trials have concluded that too few studies have 
been conducted to draw clear conclusions about the treat­
ment of this form of personality disorder, but they have high­
lighted the limited, if any, impact of pharmacological treat­
ments and the promising, if still unclear, benefits of complex 
psychosocial interventions such as dialectical behaviour 
therapy (27,28).
The treatment of people with borderline personality dis­
order has also been reviewed as part of the development of 
national guidelines. Following the publication of the Amer­
ican Psychiatric Association’s guidelines in 2001 (29), the 
National Institute for Clinical Excellence in England (NICE) 
published new treatment guidelines for borderline and anti­
social personality disorder (30,31). The evidence base led to 
three main conclusions: a) psychotropic drugs are of no 
proven value in the long term in these personality disorders, 
and their adverse effects normally preclude their use except 
for short periods and in crisis; b) if other treatments (mainly 
psychological) are to be given, they need to be administered 
using a structured team approach for borderline personality 
disorder and using cognitive therapeutic approaches (par­
ticularly group management) in antisocial personality disor­
der; c) in antisocial personality disorder, interventions that 
reward are better than those that punish.
Information on which to base treatment discussions for 
people with other forms of personality disorder is even more 
scant. Recent trials by Svartberg et al (32) and Emmelkamp 
et al (33) are noteworthy because they examined the impact 
of psychological treatments among people with cluster C 
personality disorders. Findings from these two trials dis­
agree, with Emmelkamp et al demonstrating greater im­
provement among those offered 20 sessions of cognitive 
therapy compared to psychodynamic psychotherapy, while 
Svartberg et al found similar treatment outcomes among 
those receiving these two interventions.
For other forms of personality disorder in which the pa­
tients are treatment resisting (Type R) (i.e., they do not want 
their personalities to change), as opposed to treatment seek­
ing (Type S) (25), it may be better to try and adapt the envi­
ronment to the personality and this can be done systemati­
cally in the form of nidotherapy (34,35). This has received 
support in a recent randomized trial (36).
Most of the putative successful treatments for personality 
disorder are time consuming and resource intensive, and 
need to be buttressed by a good theoretical base and thera­
peutic commitment. These conclusions match those of an 
expert panel on the management of people with personality 
disorder (37), which also suggested that there is no “quick 
fix” in the treatment of these disorders, and that in most 
countries the resources are not likely to be available to treat 
them in this way.
While research for treatment of personality disorder that 
goes beyond the previous focus on borderline personality 
disorder is to be welcomed, findings from other studies show 
that in clinical practice people offered treatment usually 
meet diagnostic criteria for several categories of personality 
disorders (38,39). Such findings add weight to the case for 
re-classifying personality disorder to ensure that the system 
used has clinical utility.
NEED FOR A NEW CLASSIFICATION
If we accept the epidemiological figures, 3-10% of the 
adult inhabitants in the countries of the world have a per­
sonality disorder. However, only a minority of these (prob­
ably one in 20) has a severe personality disorder (40) and it 
is the people in this group who cause the most disruption to 
services and to society.
For the most severe personality disorders, the existing 
classification is unhelpful. It takes no account of severity 
and it generates the frequent comorbidity of several person­
ality disorders across different clusters (41), as well as the 
frequent use of the term “personality disorder not otherwise 
specified”, which, when often used more than any specific 
personality category, is a mark of dissatisfaction with the 
existing classification (42).
The WPA Section on Personality Disorders is currently 
examining new ways of classifying personality disorder in 
ICD-11. As well as making suggestions over the classifica­
tion of severity discussed above, the Section is considering 
revising the descriptions of the major personality disorder 
groupings. These would be fewer, overlap less and, we hope, 
possess greater clinical utility.
There is surprising consistency over the number and de­
scriptions of the main dimensions of personality disorder in 
studies carried out with both psychiatric patients and nor­
mal populations. Three or four dimensions are uniformly 
reported (43-46), in addition to the well-known five-factor 
model (47) that has been suggested for the core descriptions 
of DSM-V personality disorders (48).
The first dimension is an externalizing potentially aggres­
sive and hostile factor that incorporates borderline, antiso­
cial, narcissistic, histrionic (cluster B in DSM-IV) and often 
paranoid personality disorder traits. Some studies report a 
separation of a factor incorporating callousness, lack of re­
morse and criminal behaviour (psychopathy), while others 
find a single broad factor. The second dimension is gener­
ally an internalizing factor consisting of neurotic, inhibited 
and avoidant, incorporating anxious, behaviour. This was 
once called asthenia, but is now best summarized as avoidant 
and dependent personality disorder traits (part of cluster C) 
in DSM-IV. The third dimension comprises schizoid symp­
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toms: introversion and social indifference, aloofness and 
restricted expression of affect. In some studies these charac­
teristics overlap with eccentric and odd behaviour and/or 
paranoid personality disorder symptoms, and an additional 
factor, peculiarity, has been suggested to make up a six-fac­
tor model (49). The fourth factor comprises obsessionality, 
compulsivity and perfectionism and, although these are cur­
rently part of the cluster C grouping, the empirical data sug­
gests they can be separated. In some studies this forms part 
of the internalizing factor, but most investigations report 
that obsessive compulsive personality disorder symptoms 
split off as a coherent and relatively independent set of be­
haviours.
While there is currently little evidence to support the va­
lidity of these factors, they almost certainly provide a better 
description of the range of personality abnormality than the 
current classifications. They can also be adapted to a devel­
opmental perspective that will allow personality disturbance 
to be identified long before the current cut-off age of 18 that 
is intrinsic to both DSM-IV and ICD-10 (50). Their impor­
tance will rest on whether they provide a more useful frame­
work for organizing and explaining the complexity of clini­
cal experience in personality disorders as well as predicting 
outcome and guiding decisions about treatment (51). Anew 
classification that does not improve clinical utility will be a 
failed classification.
There seems little to lose. A recent survey reported that 
three quarters of personality disorder experts thought the 
current DSM-IV system should be replaced (42). Using four 
(or possibly more) overlapping factors seems preferable to 
continuing to act as though the ten current personality dis­
orders are separate, when they have repeatedly been found 
not to be.
The next step will be to derive better structured clinical 
interviews that address these factors well, and this should 
generate competent research which can explore whether 
knowledge about aetiology, prognosis and treatment is en­
hanced by using the new classification.
The DSM-IV polythetic diagnoses describe poorly speci­
fied psychopathology and so it is natural that they fail to 
identify criteria that could correspond to the “core features” 
of each personality disorder diagnosis. The lack of clearly 
identified core features and a “vote-counting” approach to 
personality disorder diagnosis (i.e., list the number of symp­
toms that were met by a given subject, see if it is greater than 
a usually arbitrary cut-off value, and then make the diagno­
sis) prevented clinicians from making differential diagnoses 
within the axis II classification. The legacy is a diagnostic 
system that dissatisfies both the researcher and the clinician, 
being neither simple, accurate or useful. Thus, although it 
has promoted a huge, but widely scattered, amount of re­
search on the aetiology, psychopathology, course and treat­
ment of personality disorders, there are now good reasons 
to consider the DSM-IV approach completely out of date.
The WPA Section on Personality Disorders is currently 
considering revising the descriptions of the major personal­
ity disorder groupings in a way that not only makes good 
clinical sense but also enables separation from other disor­
ders with which they are frequently confused, such as atten- 
tion-deficit/hyperactivity disorder (ADHD) (52). It will not 
be an easy task, and in reaching our conclusions we hope to 
have empirical evidence from as many field trials as possible, 
not just in highly developed countries, as a robust classifica­
tion should travel well (53), and to use these data rather than 
relying on the uncertain support of consensus committee 
opinion, as previous classifications have unfortunately been 
forced to do.
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